Patterns of Failure and Determinants of Outcomes Following Radical Re-resection for Incidental Gallbladder Cancer

被引:39
作者
Barreto, Savio George [1 ]
Pawar, Satish [1 ]
Shah, Sanket [1 ]
Talole, Sanjay [2 ]
Goel, Mahesh [1 ]
Shrikhande, Shailesh V. [1 ,3 ]
机构
[1] Tata Mem Hosp, Dept Gastrointestinal & Hepatopancreatobiliary Su, Mumbai 400012, Maharashtra, India
[2] Tata Mem Hosp, Dept Biostat & Epidemiol, Bombay 400012, Maharashtra, India
[3] Tata Mem Hosp, GI Management Grp, Bombay 400012, Maharashtra, India
关键词
CHEMOTHERAPY; SURVIVAL; SURGERY; DISEASE; SYSTEM;
D O I
10.1007/s00268-013-2266-4
中图分类号
R61 [外科手术学];
学科分类号
摘要
Better appreciation of the course and factors that influence incidental gallbladder cancer is needed to develop treatment strategies aimed at improved outcomes. The purpose of this study was to determine pattern of disease recurrence and influencing factors in patients undergoing radical re-resection for incidental gallbladder cancer. Patients undergoing radical re-resection from February 2003 to May 2010 were analyzed. Influence of variables (lymph node ratio, ASA grade, gender, adjuvant treatment, time interval between cholecystectomy and radical re-resection (in months), and TNM stage) on disease-free survival was assessed. Of 163 patients, 127 (92 female and 35 male patients; median age 50 years) underwent successful radical re-resection. Median duration between two surgeries was 2 months (range 1-10). Twenty-five percent of patients with pT1b disease had lymph node metastases. Two-year disease-free survival rate was 79.6 % (median follow-up, 16 months). On follow-up, 18 of 24 patients developed recurrences at distant sites. Lymph node metastasis was the single variable significantly influencing disease-free survival. Adjusting for disease stage when analyzing time interval between cholecystectomy and radical re-resection on a continuous scale as a prognostic factor for recurrence revealed no significant impact of increasing interval between surgeries (hazard ratio 1.12; 95 % confidence interval 0.95-1.34; p = 0.17). The most important predictor of disease recurrence is lymph node metastases. In patients who undergo curative radical re-resection for incidental gallbladder cancer, recurrent disease is more likely to occur at distant sites. Patients with pT1b disease should be offered radical re-resection with a radical lymphadenectomy. It is not the delay in revision surgery but TNM stage that influences outcomes in incidental gallbladder cancer.
引用
收藏
页码:484 / 489
页数:6
相关论文
共 25 条
  • [1] Gallbladder cancer, a vanishing disease?
    Alexander, S.
    Lemmens, V. E. P. P.
    Houterman, S.
    Nollen, L.
    Roumen, R.
    Slooter, G. D.
    [J]. CANCER CAUSES & CONTROL, 2012, 23 (10) : 1705 - 1709
  • [2] Gallbladder cancer: Past, present and an uncertain future
    Boutros, C.
    Gary, M.
    Baldwin, K.
    Somasundar, P.
    [J]. SURGICAL ONCOLOGY-OXFORD, 2012, 21 (04): : E183 - E191
  • [3] Curado MP., 2007, CANC INCIDENCE 5 CON
  • [4] Early Gallbladder Cancer: Is Further Treatment Necessary?
    De Aretxabala, Xabier
    Roa, Ivan
    Hepp, Juan
    Maluenda, Fernando
    Mordojovich, Gerardo
    Leon, Jorge
    Carlos Roa, Juan
    [J]. JOURNAL OF SURGICAL ONCOLOGY, 2009, 100 (07) : 589 - 593
  • [5] Dhir V, 1999, Indian J Gastroenterol, V18, P24
  • [6] Is gallbladder cancer decreasing in view of increasing laparoscopic cholecystectomy?
    Di Le, My
    Henson, Donald
    Young, Heather
    Albores-Saavedra, Jorge
    [J]. ANNALS OF HEPATOLOGY, 2011, 10 (03) : 306 - 314
  • [7] A Phase II study of gemcitabine and cisplatin in chemotherapy-naive, unresectable gall bladder cancer
    Doval, DC
    Sekhon, JS
    Gupta, SK
    Fuloria, J
    Shukla, VK
    Gupta, S
    Awasthy, BS
    [J]. BRITISH JOURNAL OF CANCER, 2004, 90 (08) : 1516 - 1520
  • [8] Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008
    Ferlay, Jacques
    Shin, Hai-Rim
    Bray, Freddie
    Forman, David
    Mathers, Colin
    Parkin, Donald Maxwell
    [J]. INTERNATIONAL JOURNAL OF CANCER, 2010, 127 (12) : 2893 - 2917
  • [9] Neither Neoadjuvant nor Adjuvant Therapy Increases Survival After Biliary Tract Cancer Resection with Wide Negative Margins
    Glazer, Evan S.
    Liu, Ping
    Abdalla, Eddie K.
    Vauthey, Jean-Nicolas
    Curley, Steven A.
    [J]. JOURNAL OF GASTROINTESTINAL SURGERY, 2012, 16 (09) : 1666 - 1671
  • [10] Adjuvant Therapy in the Treatment of Biliary Tract Cancer: A Systematic Review and Meta-Analysis
    Horgan, Anne M.
    Amir, Eitan
    Walter, Thomas
    Knox, Jennifer J.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (16) : 1934 - 1940